Patients who have tried and failed previous treatments
Patients who would like to avoid drug side effects
Patients who are looking for more personalized medication
Why CoGenesis® Cardio-Haema?
Team of world-class professionals
Rigorous accuracy and accreditation
Updated recommendation guidelines
Coronary artery disease
Congestive heart failure (CHF)
Deep vein thrombosis
Left ventricular dysfunction
Acute myocardial infarction
Drugs covered in CoGenesis® Cardio-Haema
Agonist of the c-mpl (TpoR) receptor
Treat angina pectoris
Clinical action for each drug
Individualized genotype and phenotype detections
Implications for detected phenotype
Drug prescription recommendation
Order and receive a saliva collection kit.
Register the sample collection tube barcode online, then take a
Mail the kit back to Codex’s laboratory for analysis.
Results are provided to you securely on the Codex website within six
weeks from receipt of sample.
An alternative medicine for a different metabolism
It is possible to personalize a drug to avoid known side effects. For
example, patients with a SLCO1B1 gene mutation taking simvastatin are
more likely to experience a side effect such as muscle weakness. They
can undergo genetic testing to optimize their prescription plan,
either by lowering the dose or receiving a different statin.
# The interpretation of sequencing variants is based on the current
understanding of the variants at the time it was observed, which may change
over time as more information about the genes becomes available. Not all
variants are represented in this report.
Disclaimer: The interpretations and clinical annotations provided by
Codex are intended solely for use by a medical professional and do not
constitute medical advice by Codex. Test results shown on this report
require clinical interpretation and comments by a specialist of the
respective discipline. The pharmacokinetics of a drug might be affected by
the dosage form and route of administration. Please consult a qualified
healthcare professional before making decisions about medical conditions or
before starting and stopping any prescribed treatment. The treating
providers are ultimately responsible for all diagnoses and treatments. The
report and recommendations are based on the guidelines provided by CPIC1 and
do not take into account other genetic variants and environmental or social
factors that may affect the drug response. Other factors not included in
this report include, but are not limited to, environmental factors (e.g.,
smoking), health factors (e.g., diet), social factors, various medical
conditions, and other concurrent medications. Off-label drug uses are not
considered in this report. The recommendations in the report are for the
corresponding drugs only, and the drug-drug interactions are not considered.
As a matter of practice, Codex will routinely update its database as new
information becomes available to the scientific community. Annotations and
recommendations are therefore dependent on the date of generation and/or the
database version used to generate that report.